R. Herrmann

1.4k total citations
45 papers, 1.1k citations indexed

About

R. Herrmann is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, R. Herrmann has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Surgery. Recurrent topics in R. Herrmann's work include Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (12 papers) and Lung Cancer Treatments and Mutations (8 papers). R. Herrmann is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Gastric Cancer Management and Outcomes (12 papers) and Lung Cancer Treatments and Mutations (8 papers). R. Herrmann collaborates with scholars based in Switzerland, Germany and Italy. R. Herrmann's co-authors include Helmut R. Maëcke, Andreas Otte, Martin Béhé, A. Heppeler, Bengt Glimelius, Markus Borner, A. Roth, R. Morant, Nicholas J. Petrelli and Frank H. Valone and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Annals of Oncology.

In The Last Decade

R. Herrmann

40 papers receiving 1.1k citations

Peers

R. Herrmann
Michael Doukas Netherlands
Shahzad Raza United States
Anne Cairoli Switzerland
Filipe Martins Switzerland
Sandra J. Casak United States
Michael Doukas Netherlands
R. Herrmann
Citations per year, relative to R. Herrmann R. Herrmann (= 1×) peers Michael Doukas

Countries citing papers authored by R. Herrmann

Since Specialization
Citations

This map shows the geographic impact of R. Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Herrmann more than expected).

Fields of papers citing papers by R. Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Herrmann. The network helps show where R. Herrmann may publish in the future.

Co-authorship network of co-authors of R. Herrmann

This figure shows the co-authorship network connecting the top 25 collaborators of R. Herrmann. A scholar is included among the top collaborators of R. Herrmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Herrmann. R. Herrmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laffer, U, U Metzger, P Aeberhard, et al.. (2008). Adjuvant perioperative portal vein or peripheral intravenous chemotherapy for potentially curative colorectal cancer: long-term results of a randomized controlled trial. International Journal of Colorectal Disease. 23(12). 1233–1241. 15 indexed citations
2.
Meier, G., Christian Waldherr, R. Herrmann, et al.. (2004). Successful Targeted Radiotherapy with <sup>90</sup>Y-DOTATOC in a Patient with Merkel Cell Carcinoma. Oncology. 66(2). 160–163. 40 indexed citations
3.
Herrmann, R., et al.. (2001). Risk Factors for Congenital Umbilical Hernia in German Fleckvieh. The Veterinary Journal. 162(3). 233–240. 24 indexed citations
4.
Herrmann, R., et al.. (2000). Investigations on occurrence of congenital umbilical hernia in German Fleckvieh.. Züchtungskunde. 72(4). 258–273. 4 indexed citations
5.
Doll, K., et al.. (2000). Clinical and economic importance of congenital umbilical hernias in Simmental calves.. 81(4). 327–333. 1 indexed citations
6.
Roth, A., Rudolf Maibach, Giovanni Martinelli, et al.. (2000). Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma. Annals of Oncology. 11(3). 301–306. 174 indexed citations
8.
Rochlitz, Christoph, Andreas Lohri, B van Hille, et al.. (1997). MTS1 expression and prognosis in acute myeloid leukemia. Annals of Hematology. 75(4). 141–144.
9.
Bleiberg, Harry, B. Gérard, J. Wils, et al.. (1997). Gastrointestinal Tract Cancer Liaison Office: An attempt to organise clinical research in Europe. European Journal of Cancer. 33(10). 1536–1545.
10.
Roth, A, Giovanni Martinelli, Nicola Fazio, et al.. (1997). Taxotere-cisplatin (TC) in advanced gastric carcinoma (AGC): A promising drug combination. European Journal of Cancer. 33. S275–S276. 2 indexed citations
11.
Piedbois, Pascal, Marc Buyse, G.H. Blijham, et al.. (1994). Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Journal of Clinical Oncology. 12(5). 960–969. 162 indexed citations
12.
Herrmann, R.. (1994). Systemic treatment of colorectal cancer. European Journal of Cancer. 30(3). 404–409. 5 indexed citations
13.
Mohr, Brigitte, R. Herrmann, & D. Huhn. (1993). Recombinant Human Erythropoietin in Patients with Myelodysplastic Syndrome and Myelofibrosis. Acta Haematologica. 90(2). 65–70. 19 indexed citations
14.
Herrmann, R.. (1993). Systemic treatment of colorectal cancer. European Journal of Cancer. 29(4). 583–586. 21 indexed citations
15.
Hohenberger, Peter, P. Schlag, R. Herrmann, & U. Räth. (1989). Intrahepatic 5-FU Retreatment of Liver Metastases of Colorectal Cancer That Were Progressive Under Previous Systemic Chemotherapy. American Journal of Clinical Oncology. 12(5). 447–452. 4 indexed citations
16.
Schlag, P., R. Herrmann, U. Raeth, et al.. (1988). Preoperative (Neoadjuvant) Chemotherapy in Squamous Cell Cancer of the Esophagus. Recent results in cancer research. 110. 14–20. 6 indexed citations
17.
Schlag, P., et al.. (1988). Preoperative Chemotherapy in Esophageal Cancer: A phase II study. Acta Oncologica. 27(6). 811–814. 17 indexed citations
18.
Schlag, P., R. Herrmann, U. Raeth, et al.. (1987). 23. Properative Chemotherapie beim Oesophagus-Carcinom: Vorteile oder Gefahr fr den chirurgischen Eingriff?@@@Preoperative chemotherapy in esophageal cancer ? credits and debits for surgery. Langenbecks Archiv für Chirurgie. 372(1). 155–160. 3 indexed citations
19.
Flechtner, Hans‐Henning, W. Queißer, Manfred Heim, et al.. (1987). 5-Fluorouracil, 4-Epidoxorubicin, and Mitomycin C (FEM) Combination Chemotherapy for Advanced Gastric Carcinoma. A Phase-II Trial by the “Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)”. Oncology Research and Treatment. 10(2). 67–71. 5 indexed citations
20.
Schlag, P., R. Herrmann, U. Raeth, et al.. (1987). 23. Pr�operative Chemotherapie beim Oesophagus-Carcinom: Vorteile oder Gefahr f�r den chirurgischen Eingriff?. Langenbeck s Archives of Surgery. 372(1). 155–160. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026